-+ 0.00%
-+ 0.00%
-+ 0.00%

10x Genomics Management Commentary: Consumables Strength Drives 1% Revenue Growth in Q3 2026

PUBT·11/05/2026 23:43:43
Listen to the news
10x Genomics Management Commentary: Consumables Strength Drives 1% Revenue Growth in Q3 2026
  • In earnings commentary, 10x Genomics management raised full-year 2026 revenue guidance to $625 million-$635 million from $610 million-$630 million.
  • Third-quarter revenue rose 1% to $150.7 million, supported by 5% consumables growth.
  • Instrument revenue fell 43%, primarily reflecting fewer units sold as customers delayed spatial instrument purchases ahead of Atera.
  • Stronger spatial consumables supported the higher outlook; management increased expected Atera shipments to approximately 50 instruments from 40 by year-end.
  • Gross margin increased to 75% from 67%, driven primarily by lower inventory write-downs and changes in product mix.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.